Jones and Somaiah Review the Rationale and Design of the Pea

Drs Jones and Somaiah discuss unmet needs in GIST that the Peak trial seeks to answer; the advantages of the methods and design of this trial; and how the tolerable safety profile of bezuclastinib plus sunitinib supports further research with this combination.

Related Keywords

London , City Of , United Kingdom , Texas , United States , Houston , Neeta Somaiah , Robin Jones , Ashling Wahner , University Of Texas Md Anderson Cancer Center , Linkedin , Division Of Cancer Medicine , Department Of Sarcoma Medical Oncology , Facebook , Twitter , Cogent Biosciences , Sarcoma Unit , Royal Marsden , Sarcoma Medical Oncology , Cancer Medicine , Cancer Center , Drs Jones , Apple Podcasts , Google Podcasts , Amazon Music , D , Orcp , Peak Trial , Nct05208047 , Patients With Gastrointestinal Stromal Tumor , The Royal Marsden Nhs Foundation Trust , The University Of Texas Md Anderson Cancer Center , Bezuclastinib Plus Sunitinib ,